gsk1247446a
Vaccineexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2006 (NCT00321763)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gsk1247446a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00363077 | Phase 2 | Oct 1, 2006 | GlaxoSmithKline |
| NCT00374842 | Phase 2 | Oct 1, 2006 | GlaxoSmithKline |
| NCT00321373 | Phase 2 | May 1, 2006 | GlaxoSmithKline |
| NCT00321763 | Phase 2 | Apr 1, 2006 | GlaxoSmithKline |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 4 | 4 | 1 | 2006 |
1 organizations
Page 1 / 1